IMMIX BIOPHARMA INC (IMMX)
US45258H1068 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 17.51M | 13.44M | 17.64M | 390.00K | 730.00K | |||
| Receivables | 1.17M | 260.00K | 30.00K | 130.00K | 180.00K | |||
| Other Current Assets | 1.11M | 1.21M | 520.00K | 10.00K | 20.00K | |||
| Total Current Assets | 19.79M | 14.90M | 18.19M | 530.00K | 930.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 50.18K | 0.00 | 10.00K | 10.00K | 10.00K | |||
| Other Non-Current Assets | 87.23K | 10.00K | N/A | N/A | N/A | |||
| Total Non-Current Assets | 137.41K | 10.00K | 0.00 | 10.00K | 10.00K | |||
| TOTAL ASSETS | 19.93M | 14.91M | 18.19M | 540.00K | 940.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 50.00K | 4.10M | 4.10M | |||
| Accrued Expenses | 2.29M | 0.00 | 10.00K | 340.00K | 240.00K | |||
| Accounts Payable | 1.43M | 1.27M | 140.00K | 250.00K | 250.00K | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 580.00K | 0.00 | |||
| Total Current Liabilities | 3.72M | 1.27M | 200.00K | 5.27M | 4.59M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 480.00K | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | -201.73K | 480.00K | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 3.52M | 1.75M | 200.00K | 5.27M | 4.59M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -53.41M | -37.99M | -29.76M | -5.37M | -4.22M | |||
| Additional Paid In Capital | 69.78M | 51.16M | 47.62M | 510.00K | 510.00K | |||
| Minority Interest | -32.27K | N/A | N/A | N/A | N/A | |||
| Common Shares | 2.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -99.96K | -100.00K | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 134.67K | 90.00K | 130.00K | 130.00K | 70.00K | |||
| Shares Outstanding | 19.92M | 13.89M | 13.23M | 7.20M | 7.20M | |||
| Tangible Book Value per Share | 0.82 | 0.95 | 1.36 | -0.66 | -0.51 | |||
| Total Shareholders' Equity | 16.41M | 13.16M | 17.99M | -4.73M | -3.65M | |||
| TOTAL LIABILITIES AND EQUITY | 19.93M | 14.91M | 18.19M | 540.00K | 940.00K | |||
| Statistics | ||||||||
| Current Ratio | 5.32 | 11.73 | 90.95 | 0.10 | 0.20 | |||
| Return On Assets (ROA) | -77.42% | -55.20% | -134.03% | -212.96% | -103.19% | |||
| Return On Equity (ROE) | -94.03% | -62.54% | -135.52% | N/A | N/A | |||
All data in USD